Birth Weight, Childhood Weight Gain Linked to Non-Hodgkin Lymphoma Risk - The American Journal of Managed Care
Birth Weight, Childhood Weight Gain Linked to Non-Hodgkin Lymphoma Risk The American Journal of Managed Care
Hodgkin Lymphoma News
VB star Kenna Wollard diagnosed with non-Hodgkin lymphoma, on track to remission - Purdue Exponent
VB star Kenna Wollard diagnosed with non-Hodgkin lymphoma, on track to remission Purdue Exponent
From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma - Cureus
From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma Cureus
Jennifer Geel: How Is Science Transforming the Future of Hodgkin Lymphoma Treatment? - Oncodaily
Jennifer Geel: How Is Science Transforming the Future of Hodgkin Lymphoma Treatment? Oncodaily
Former IVC, now Purdue volleyball star Kenna Wollard, shares cancer diagnosis, update - Yahoo Sports
Former IVC, now Purdue volleyball star Kenna Wollard, shares cancer diagnosis, update Yahoo Sports
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up - Wiley Online Library
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up Wiley Online Library
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds - The ASCO Post
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds The ASCO Post
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal - Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal Nature
Understanding Hodgkin lymphoma cell origins could yield better diagnostics - Cornell Chronicle
Understanding Hodgkin lymphoma cell origins could yield better diagnostics Cornell Chronicle
Hodgkin Lymphoma: Leah’s Story - Johns Hopkins Medicine
Hodgkin Lymphoma: Leah’s Story Johns Hopkins Medicine
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - UT MD Anderson
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult UT MD Anderson
Hodgkin Lymphoma Survivor and TV Producer Mike Burg Turns His Experience Into Decades of Advocacy - Atrium Health
Hodgkin Lymphoma Survivor and TV Producer Mike Burg Turns His Experience Into Decades of Advocacy Atrium Health
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Frontiers
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” Frontiers
Purdue volleyball All-American reveals why she's out for season with positive prognosis - IndyStar
Purdue volleyball All-American reveals why she's out for season with positive prognosis IndyStar
Transformation of Mixed Cellularity Classical Hodgkin Lymphoma to Diffuse Large B-cell Lymphoma: A Case Report and Literature Review - Cureus
Transformation of Mixed Cellularity Classical Hodgkin Lymphoma to Diffuse Large B-cell Lymphoma: A Case Report and Literature Review Cureus
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin - Nature
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma - Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma Nature
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia - Nature
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma - CancerNetwork
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase - CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase CancerNetwork
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial - Journal of Nuclear Medicine
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial Journal of Nuclear Medicine
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma - Clemson University Athletics
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma Clemson University Athletics
Clarkston twins beat Hodgkin’s lymphoma, head off to college - ClickOnDetroit | WDIV Local 4
Clarkston twins beat Hodgkin’s lymphoma, head off to college ClickOnDetroit | WDIV Local 4
PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma - OncLive
PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma OncLive
Brescia, Hodgkin Lymphoma - Lymphoma Research Foundation
Brescia, Hodgkin Lymphoma Lymphoma Research Foundation
Long-Term Hodgkin Lymphoma Survivors Have Increased Risk of All-Cause Mortality - Cancer Therapy Advisor
Long-Term Hodgkin Lymphoma Survivors Have Increased Risk of All-Cause Mortality Cancer Therapy Advisor
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition - Inside Precision Medicine
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition Inside Precision Medicine
Evaluation of Lymphadenopathy in Urgent Care: A Case of Hodgkin Lymphoma - Cureus
Evaluation of Lymphadenopathy in Urgent Care: A Case of Hodgkin Lymphoma Cureus
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study - Nature
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study Nature
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group - The Lancet
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group The Lancet
Four-Drug Regimen Induces High Complete Response Rate in Early-Stage Classical Hodgkin Lymphoma - The ASCO Post
Four-Drug Regimen Induces High Complete Response Rate in Early-Stage Classical Hodgkin Lymphoma The ASCO Post
Acute Disseminated Encephalomyelitis Following Nivolumab Therapy for Hodgkin Lymphoma: A Case Report and Literature Review - Cureus
Acute Disseminated Encephalomyelitis Following Nivolumab Therapy for Hodgkin Lymphoma: A Case Report and Literature Review Cureus
Lena, Hodgkin Lymphoma Care Partner - Lymphoma Research Foundation
Lena, Hodgkin Lymphoma Care Partner Lymphoma Research Foundation
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation - Wiley Online Library
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation Wiley Online Library
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma - UT MD Anderson
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma UT MD Anderson
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature